Abstract Recent large clinical trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, with the aim of verifying cardiovascular safety, have revealed that these medications have a preventative advantage on adverse cardiovascular outcomes, including worsening of heart failure and deterioration of nephropathy, in patients with type 2 diabetes (T2D)
Individuals who are sensitive to changes in blood glucose levels, those with a history of gastrointestinal issues, or patients taking other medications that affect blood pressure may be more prone to experiencing dizziness with semaglutide
Your provider can help you transition safely or maintain results with supportive supplements, nutrition strategies, and ongoing care
And no, it does not mean you should stop training
For collagen, look for "hydrolyzed" peptides, which are already broken down into smaller, more absorbable pieces
Contents show A Personalized Approach to Semaglutide Weight Loss Semaglutide may be recommended for eligible adults seeking physician-guided support for obesity, weight-related health conditions, or long-term weight management